Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06198010 · ClinicalTrials.gov registry record · NA

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors (ASCENT)

A NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
660
Enrollment target
3
Study locations

NCT06198010: Recruiting NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, sponsored by Mayo Clinic.

NCT06198010 is a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 660 participants, below the 1,137-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (42% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06198010, a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
660 participants
Enrollment target
3
Study locations

Study Summary

This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care models show promise for cancer pain in controlled settings. All cancer survivors stand to benefit from electronic health record innovations, as they can experience profound pain outcomes, including marked under- and over-prescribing of opioids. Digitally facilitated solutions are especially helpful and can be customized to address patient needs. The ASCENT intervention provides patients with an educational guide that describes techniques for addressing cancer pain, and uses community health workers and pain care managers to coach patients through a personalized pain management plan. This study may help researchers learn how pain management strategies can improve cancer pain and lower risk of opioid exposure and dependency in cancer survivors.

Primary Outcome

Will be measured using the Brief Pain Inventory Short Form (BPI SF), a 4-item questionnaire answered on a scale from 0 (no pain) to 10 (pain as bad as you can imagine). A higher score indicates worse pain.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • OTHER Educational Intervention
  • OTHER Electronic Health Record Review
  • PROCEDURE Health Telemonitoring

Study Locations (3)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Florida

  • Mayo Clinic in Florida - Jacksonville

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 660 participants
Start Date 2024-02-07
Est. Completion 2027-08-31
Phase NA
Mayo Clinic

2,844 total trials

What NCT06198010 shows while recruiting

NCT06198010 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, below the 1,137-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (42% lower).

The record links to 3 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.

NCT06198010 reports a single indexed study location in Arizona, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT06198010 about?

NCT06198010 is a clinical study titled "A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors (ASCENT)". This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care...

What is the current status of trial NCT06198010?

This trial is currently recruiting. It is a NA study. The enrollment target is 660 participants. The study started on 2024-02-07. Estimated completion is 2027-08-31.

What conditions does trial NCT06198010 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Hematopoietic and Lymphoid System Neoplasm.

What interventions are being tested in trial NCT06198010?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Educational Intervention (OTHER), Electronic Health Record Review (OTHER), Health Telemonitoring (PROCEDURE).

Who is sponsoring clinical trial NCT06198010?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06198010 being conducted?

This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06198010's enrollment target sits among peer trials

660 24th of 176 higher than 153 of 176 other Malignant Solid Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01185132 · 660 participants · Phase 3

    Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

  • NCT03346694 · 660 participants · NA

    Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing

  • NCT05407636 · 660 participants · Phase 3

    Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

  • NCT05470205 · 660 participants · Phase 3

    Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06198010, the US trial registry maintained by the National Library of Medicine. NCT06198010 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.